NCT00256217View on ClinicalTrials.gov

Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women

PHASE2CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

September 21, 2004

Primary Completion Date

December 12, 2018

Study Completion Date

December 12, 2018

Conditions

DCIS

Interventions

DRUG

Anastrozole

1 mg. oral every day for 2 - 4 weeks

Trial Locations (1)

92868

Chao Family Comprehensive Cancer Center, Orange

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Rita Sanghvi, Mehta

OTHER